New Edge Advisors, LLC Ani Pharmaceuticals Inc Transaction History
New Edge Advisors, LLC
- $16.2 Billion
- Q1 2025
A detailed history of New Edge Advisors, LLC transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, New Edge Advisors, LLC holds 75 shares of ANIP stock, worth $4,374. This represents 0.0% of its overall portfolio holdings.
Number of Shares
75Holding current value
$4,374% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ANIP
# of Institutions
239Shares Held
20.2MCall Options Held
7.4KPut Options Held
12.4K-
Black Rock Inc. New York, NY2.66MShares$155 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.18MShares$68.9 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny818KShares$47.7 Million0.03% of portfolio
-
Global Alpha Capital Management Ltd.736KShares$42.9 Million3.53% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il723KShares$42.2 Million0.01% of portfolio
About ANI PHARMACEUTICALS INC
- Ticker ANIP
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 17,426,000
- Market Cap $1.02B
- Description
- ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...